Oppenheimer Maintains a 'Perform' on Auxilium Pharmaceuticals (AUXL); Reaching Out To Urologists

June 14, 2012 8:56 AM EDT Send to a Friend
Oppenheimer maintains a 'Perform' on Auxilium Pharmaceuticals (NASDAQ: AUXL).

Analyst, Chrstopher Holterhoff, said, "On the heels of positive results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login